|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.4490 - 0.5190|
|52 Week Range||0.3500 - 1.5100|
|Beta (5Y Monthly)||-0.61|
|PE Ratio (TTM)||2.87|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Jun 15, 2016|
|1y Target Est||N/A|
Indivior PLC (LON: INDV) today announced that its full year 2019 press release is now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Investors" section of the company's website at www.indivior.com.
Indivior PLC (LON: INDV) today announced a new research collaboration with Virginia Tech extending the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery) Study ™. RECOVER is a multisite, non-interventional cohort study examining long-term recovery in individuals with moderate to severe opioid use disorder who received at least one dose of study treatment during the SUBLOCADE Phase 3 clinical trials (NCT02357901 and NCT02510014). ¹ The study design and participant characteristics of the RECOVER study can be found in Contemporary Clinical Trials.2 This study will be led by a team of researchers at the Fralin Biomedical Research Institute at Virginia Tech Carilion.